$-0.02 EPS Expected for Rite Aid Corporation (RAD)

September 3, 2017 – By Adrian Mccoy

 $ 0.02 EPS Expected for Rite Aid Corporation (RAD)
Investors sentiment decreased to 0.92 in Q4 2016. Its down 0.26, from 1.18 in 2016Q3. It is negative, as 67 investors sold Rite Aid Corporation shares while 114 reduced holdings. 39 funds opened positions while 128 raised stakes. 598.79 million shares or 0.81% more from 593.98 million shares in 2016Q3 were reported.
Invesco has invested 0% of its portfolio in Rite Aid Corporation (NYSE:RAD). Pyrrho Cap Mngmt Lp owns 136,000 shares for 1.68% of their portfolio. State Board Of Administration Of Florida Retirement holds 0.04% of its portfolio in Rite Aid Corporation (NYSE:RAD) for 1.45M shares. Swiss Retail Bank accumulated 3.12 million shares. Moreover, Arrowgrass Capital Prns (Us) Lp has 2.02% invested in Rite Aid Corporation (NYSE:RAD). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment Mngmt holds 0.03% or 450,000 shares in its portfolio. Archford Capital Strategies Ltd Liability Company has 0.02% invested in Rite Aid Corporation (NYSE:RAD) for 5,000 shares. Cap Guardian invested in 4,840 shares. Glenmede Trust Commerce Na owns 0% invested in Rite Aid Corporation (NYSE:RAD) for 8,850 shares. Commonwealth Of Pennsylvania Pub School Empls Retrmt Sys owns 1.67 million shares. Bnp Paribas Prtn Sa invested in 40,369 shares. Shell Asset Mgmt reported 0.02% stake. 4,568 are owned by Fifth Third Savings Bank. Baldwin Brothers Inc Ma holds 0% of its portfolio in Rite Aid Corporation (NYSE:RAD) for 235 shares. Exane Derivatives reported 0% in Rite Aid Corporation (NYSE:RAD).

Wall Street await Rite Aid Corporation (NYSE:RAD) to release earnings on September, 28. Analysts forecast earnings per share of $-0.02, down exactly $0.05 or 166.67 % from 2014’s $0.03 EPS. After posting $-0.05 EPS for the previous quarter, Rite Aid Corporation’s analysts now forecast -60.00 % EPS growth. It closed at $2.42 lastly. It is down 55.18% since September 3, 2016 and is downtrending. It has underperformed by 71.88% the S&P500.

Rite Aid Corporation (NYSE:RAD) Ratings Coverage

Among 11 analysts covering Rite Aid (NYSE:RAD), 2 have Buy rating, 2 Sell and 7 Hold. Therefore 18% are positive. Rite Aid had 17 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Thursday, October 29 by Goldman Sachs. Mizuho downgraded the stock to “Neutral” rating in Thursday, July 20 report. The firm has “Buy” rating given on Friday, August 14 by Vetr. The firm has “Underperform” rating given on Friday, June 30 by Bank of America. As per Friday, November 13, the company rating was downgraded by JP Morgan. Vetr downgraded the stock to “Buy” rating in Thursday, August 6 report. The company was initiated on Thursday, August 13 by Bank of America. The rating was reinitiated by Evercore with “Underperform” on Friday, June 30. The rating was downgraded by Evercore to “Hold” on Wednesday, January 6. As per Thursday, September 17, the company rating was maintained by Mizuho.

Rite Aid Corporation is a retail drugstore chain. The company has market cap of $2.55 billion. The Company’s divisions include Retail Pharmacy and Pharmacy Services. It currently has negative earnings. The Firm operates under The Rite Aid name.

More notable recent Rite Aid Corporation (NYSE:RAD) news were published by: Seekingalpha.com which released: “Waiting For Rite Aid” on August 08, 2017, also Investorplace.com with their article: “Ugly Rite Aid Corporation (RAD) Stock Has Upside Potential, If You Can Stomach It” published on August 22, 2017, Seekingalpha.com published: “Is It The Right Time For Rite Aid?” on September 01, 2017. More interesting news about Rite Aid Corporation (NYSE:RAD) were released by: Investorplace.com and their article: “Get Ready for the Rally in Rite Aid Corporation (RAD) Stock” published on August 29, 2017 as well as Seekingalpha.com‘s news article titled: “Rite Aid: The Turning Point” with publication date: August 13, 2017.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.